# Nuclide record prostate-cancer-foundation (collection). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/collections/prostate-cancer-foundation/>
  a schema:Dataset ;
  nuclide:kind "collection" ;
  schema:identifier "prostate-cancer-foundation" ;
  schema:name "Prostate Cancer Foundation (PCF)"@en ;
  schema:description "Michael Milken's prostate cancer foundation, which funded the science behind abiraterone, enzalutamide and PSMA therapy and runs a precision-oncology network in US veterans' hospitals."@en ;
  schema:url <https://nuclide.cc/collections/prostate-cancer-foundation/>, <https://www.pcf.org/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.pcf.org/>, <https://zerocancer.org/>, <https://us.movember.com/> ;
  nuclide:tag "gap-fill", "patient-org" ;
  schema:license "Copyright PCF" ;
  nuclide:related <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/targets/psma/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/drugs/abiraterone/>, <https://nuclide.cc/drugs/enzalutamide/>, <https://nuclide.cc/isotopes/ra-223/> .